MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations

Jan Trøst Jørgensen; Edyta M Urbanska; Jens Mollerup

doi:10.21037/tlcr-24-98

MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations

Jan Trøst Jørgensen^*, Edyta M Urbanska, Jens Mollerup

^*Corresponding author af dette arbejde

Afdeling for Kræftbehandling

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Translational lung cancer research
Vol/bind	13
Udgave nummer	4
Sider (fra-til)	940-946
Antal sider	7
ISSN	2218-6751
DOI	https://doi.org/10.21037/tlcr-24-98
Status	Udgivet - 29 apr. 2024

Adgang til dokumentet

10.21037/tlcr-24-98

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{4fcde8d07a484864ad4068dc549d1a34,

title = "MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations",

keywords = "capmatinib, companion diagnostics, MET exon 14-skipping mutations (METex14), Non-small-cell lung cancer (NSCLC), tepotinib",

author = "J{\o}rgensen, {Jan Tr{\o}st} and Urbanska, {Edyta M} and Jens Mollerup",

year = "2024",

month = apr,

day = "29",

doi = "10.21037/tlcr-24-98",

language = "English",

volume = "13",

pages = "940--946",

journal = "Translational lung cancer research",

issn = "2218-6751",

publisher = "Pioneer Bioscience Publishing Company",

number = "4",

}

TY - JOUR

T1 - MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations

AU - Jørgensen, Jan Trøst

AU - Urbanska, Edyta M

AU - Mollerup, Jens

PY - 2024/4/29

Y1 - 2024/4/29

KW - capmatinib

KW - companion diagnostics

KW - MET exon 14-skipping mutations (METex14)

KW - Non-small-cell lung cancer (NSCLC)

KW - tepotinib

UR - http://www.scopus.com/inward/record.url?scp=85193446417&partnerID=8YFLogxK

U2 - 10.21037/tlcr-24-98

DO - 10.21037/tlcr-24-98

M3 - Editorial

C2 - 38736494

SN - 2218-6751

VL - 13

SP - 940

EP - 946

JO - Translational lung cancer research

JF - Translational lung cancer research

IS - 4

ER -